• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Glaukos Corporation Common Stock (NY:GKOS)

142.15 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Glaukos Corporation Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Analyst Expectations for Glaukos's Future ↗
December 28, 2022
 
Via Benzinga
10 Analysts Have This to Say About Glaukos ↗
December 28, 2022
 
Via Benzinga
News headline image
What 10 Analyst Ratings Have To Say About Glaukos ↗
December 28, 2022
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022 ↗
December 22, 2022
 
Via Benzinga
News headline image
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants ↗
December 22, 2022
This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022 ↗
December 19, 2022
 
Via Benzinga
News headline image
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday ↗
December 19, 2022
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... 
Via Benzinga
7 Analysts Have This to Say About Glaukos ↗
December 12, 2022
 
Via Benzinga
News headline image
Analyst Ratings for Glaukos ↗
December 12, 2022
 
Via Benzinga
Where Glaukos Stands With Analysts ↗
December 12, 2022
 
Via Benzinga
News headline image
Glaukos Announces Participation in the Stephens Annual Investment Conference
November 07, 2022
From Glaukos Corporation
Via Business Wire
News headline image
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday ↗
November 04, 2022
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Glaukos ↗
November 03, 2022
Analysts have provided the following ratings for Glaukos (NYSE:GKOS) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗
December 12, 2022
 
Via Benzinga
News headline image
Glaukos Corporation Announces Third Quarter 2022 Financial Results
November 02, 2022
From Glaukos Corporation
Via Business Wire
News headline image
Needham Says Recent Launches To Drive Market Share Recovery For This Eye-Focused MedTech Stock ↗
October 04, 2022
 
Via Benzinga
News headline image
Glaukos Shares Pop After Positive Data From Ocular Pressure Candidate ↗
September 07, 2022
 
Via Benzinga
News headline image
Glaukos Inks Licensing Pact For Rare Eye Disorder Treatment ↗
August 24, 2022
 
Via Benzinga
News headline image
Glaukos to Release Third Quarter 2022 Financial Results after Market Close on November 2
October 12, 2022
From Glaukos Corporation
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
September 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Academy of Ophthalmology Annual Meeting
September 28, 2022
From Glaukos Corporation
Via Business Wire
News headline image
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗
September 07, 2022
 
Via Benzinga
News headline image
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗
September 08, 2022
Gainers 
Via Benzinga
News headline image
Dow Jumps 450 Points; UiPath Shares Slide ↗
September 07, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones adding around 450 points on Wednesday. 
Via Benzinga
News headline image
Dow Up 249 Points, Nasdaq Set To Snap Skid ↗
September 07, 2022
Stocks are charging higher this afternoon, though investors are still awaiting the release of the Federal Reserve's Beige Book. 
Via Talk Markets
News headline image
Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗
September 07, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. 
Via Benzinga
News headline image
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday ↗
September 07, 2022
  
Via Benzinga
News headline image
What's Going On With Glaukos Shares? ↗
September 07, 2022
Glaukos Corp (NYSE: GKOS) shares are trading higher by 1.87% to $49.00 Wednesday morning after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved... 
Via Benzinga
News headline image
Glaukos Announces Positive Topline Outcomes for Both Phase 3 Pivotal Trials of iDose TR, Achieving Primary Efficacy Endpoints and Demonstrating Favorable Tolerability and Safety Profiles
September 07, 2022
From Glaukos Corporation
Via Business Wire
News headline image
Glaukos Announces More Than 1 Million iStent® Technologies Implanted Worldwide
September 06, 2022
From Glaukos Corporation
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap